Cigarette smoking is the leading cause of death and disability in the US, contributing to over 440,000 deaths each year. Despite awareness that smoking is a 'chronic health behavior problem,' smoking rates have stabilized in the US, most notably for smokers with elevated psychiatric symptoms and disorders. Here, anxiety and depressive symptoms and syndromes are particularly important because they are the most prevalent psychiatric symptoms in the general population, remarkably comorbid with smoking, and reliably associated with smoking initiation, maintenance, and relapse. Indeed, 'affectively-vulnerable smokers' (i.e., smokers with elevated negative mood states or psychopathology) often are more nicotine dependent, experience more mood problems when quitting, smoke more to manage negative mood states, and nicotine maintains a relatively more reinforcing effect for this group. There is a general consensus that affective-vulnerable smokers require specialty care options that address their unique 'affective needs.' One promising, integrative approach to address the heterogeneity of negative affect symptoms and disorders for smoking has been to focus on underlying transdiagnostic processes that underpin affective psychopathology and the maintenance of smoking. Anxiety sensitivity (AS), the tendency to fear anxiety-related sensations, is a core transdiagnostic vulnerability factor for the etiology and maintenance of anxiety disorders and other emotional disorders, and is also related to smoking maintenance and relapse. AS is malleable in response to psychosocial interventions, making it a prime risk factor to target in prevention/intervention programs. Although some progress has been made in terms of developing highly intensive, integrated treatments that address affective vulnerability in the context of smoking cessation, no targeted efforts have focused on 'earlier phases' of the quit process (i.e., Motivation [having motivation to quit] or Precessation [thinking about and preparing for quitting] phases) for smokers with elevated AS. Moreover, as smokers infrequently use intensive treatments for smoking cessation (consistently less than 10% across studies) because of such barriers as cost, time commitments, and logistics (e.g., travel, scheduling appointments), there is a major need to develop an accessible, brief, integrated tactic to explicitly address the smoking-affective vulnerability comorbidity. By promoting 'earlier change efforts' through focused, personalized feedback for high-risk segments of the smoking population, there is a greater chance to increase sustained and successful quit behavior. The current proposal seeks to employ a computer- delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking-AS in a personalized manner. Smokers with elevated AS (N = 130) will be randomly assigned to receive either a PFI or smoking information control (no personalized feedback) and then will be followed up to 1-month after the one- session intervention. The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.

Public Health Relevance

No computer-delivered (or web-based) brief integrated treatment exists for smokers with elevated anxiety sensitivity, a well-established transdiagnostic affective vulnerability construct associated with a heightened risk for anxiety and depressive symptoms and the maintenance of smoking in laboratory and prospective research, for smokers in the Motivation or Precessation phases of smoking. Developing an accessible, integrated tactic to explicitly address the smoking-affective vulnerability co-occurrence and promote 'earlier change efforts' in a personalized feedback manner is central to larger public health efforts to increase sustained and successful quit behavior for this highly vulnerable smoking population. This focused (integrated) feedback approach may address a crucial 'missing element' in smoking cessation care by providing an initial, yet formative, step in increasing motivation for smoking-related quit behavior (e.g., greater motivation to quit, less perceived barriers for quitting), and increased adaptive coping and greater awareness of psychological vulnerability in smokers with elevated anxiety sensitivity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31DA043390-02
Application #
9321585
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Aklin, Will
Project Start
2016-09-01
Project End
2019-08-31
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Houston
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
036837920
City
Houston
State
TX
Country
United States
Zip Code
77204
Garey, Lorra; Reitzel, Lorraine R; Neisler, Julie et al. (2018) Health-Related Quality of Life Among Homeless Smokers: Risk and Protective Factors of Latent Class Membership. Behav Med :1-12
Zvolensky, Michael J; Garey, Lorra; Fergus, Thomas A et al. (2018) Refinement of anxiety sensitivity measurement: The Short Scale Anxiety Sensitivity Index (SSASI). Psychiatry Res 269:549-557
Garey, Lorra; Peraza, Natalia; Smit, Tanya et al. (2018) Sex differences in smoking constructs and abstinence: The explanatory role of smoking outcome expectancies. Psychol Addict Behav 32:660-669
Neisler, Julie; Reitzel, Lorraine R; Garey, Lorra et al. (2018) The moderating effect of perceived social support on the relation between heaviness of smoking and quit attempts among adult homeless smokers. Drug Alcohol Depend 190:128-132
Garey, Lorra; Manning, Kara; Jardin, Charles et al. (2018) Smoking Consequences Questionnaire: A reevaluation of the psychometric properties across two independent samples of smokers. Psychol Assess 30:678-692
Neighbors, Clayton; Rodriguez, Lindsey M; Garey, Lorra et al. (2018) Testing a motivational model of delivery modality and incentives on participation in a brief alcohol intervention. Addict Behav 84:131-138
Garey, Lorra; Taha, Samar A; Kauffman, Brooke Y et al. (2017) Treatment non-response: Associations with smoking expectancies among treatment-seeking smokers. Addict Behav 73:172-177
Garey, Lorra; Reitzel, Lorraine R; Anthenien, Amber M et al. (2017) Support Buffers Financial Strain's Effect on Health-related Quality of Life. Am J Health Behav 41:497-510
Garey, Lorra; Kauffman, Brooke Y; Neighbors, Clayton et al. (2016) Treatment attrition: Associations with negative affect smoking motives and barriers to quitting among treatment-seeking smokers. Addict Behav 63:165-71